Related Experiment Video
Updated: Jun 16, 2025
14:58
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
Published on: March 5, 2022
4.1K
Comparative host transcriptomics as a tool to identify candidate biomarkers for immune reactions in leprosy using
Anuj Mavlankar1, Mukul Sharma1, Afzal Ansari1
1Department of Microbial Pathogenesis & Genomics Laboratory, Indian Council of Medical Research-National Institute of Research in Tribal Health, Jabalpur, Madhya Pradesh, India.
Indian Journal of Dermatology, Venereology and Leprology
|August 17, 2024
Summary
This study identifies potential gene biomarkers for early diagnosis of leprosy reactions. Researchers analyzed host-gene expression data to find key indicators for Type-I and Type-II leprosy reactions, aiding in better patient management.
Area of Science:
- Immunology and Infectious Diseases
- Genomics and Transcriptomics
- Dermatology
Background:
- Leprosy, curable with multidrug therapy, can cause severe nerve damage through inflammatory reactions like Type-I (reversal reaction) and Type-II (erythema nodosum leprosum).
- These leprosy reactions can lead to irreversible complications, occurring before, during, or after treatment, impacting patients with lepromatous and borderline forms.
- Currently, no accurate diagnostic tests exist for detecting these acute inflammatory leprosy reactions.
Purpose of the Study:
- To identify potential host-gene expression biomarkers for the early diagnosis of Type-I and Type-II leprosy reactions.
- To improve the management and understanding of leprosy complications through precise diagnostic markers.
Main Methods:
- Utilized host-transcriptomics data from publicly available Gene Expression Omnibus datasets.
- Performed comparative analysis and meta-analysis of four leprosy reaction datasets.
- Identified common differentially expressed genes (DEGs) using frequentist and Bayesian ratio association tests.
Main Results:
- Identified potential biomarkers for Type-II leprosy reactions, including ADAMTS5, ADAMTS9, IFITM2, IFITM3, KIRREL, ANK3, CD1E, CTSF, DOCK9, and KRT73.
- Identified potential biomarkers for Type-I leprosy reactions, including ACP5, APOC1, CCL17, S100B, and SLC11A1.
- Acknowledged limitations due to a small number of analyzed datasets (n=4), suggesting further studies are needed.
Conclusions:
- Provided a list of candidate genes that show promise as biomarkers for leprosy reactions.
- These identified genes warrant further research for their role in leprosy immune reactions and potential use in early diagnosis.
- Prioritizing these gene candidates can advance the understanding of leprosy complexities and improve diagnostic capabilities.
